Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-26-003799
Filing Date
2026-05-29
Accepted
2026-05-29 17:00:57
Documents
1
Period of Report
2026-05-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3700
  Complete submission text file 0001171843-26-003799.txt   5231
Mailing Address 100 SPY COURT MARKHAM Ontario, Canada
Business Address 100 SPY COURT MARKHAM Ontario, Canada (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 25801 INDUSTRIAL BLVD. SUITE B HAYWARD CA 94545
Business Address
Olson Charles V (Reporting) CIK: 0001663298 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37619 | Film No.: 261045756